In your opinion, what have been the most important developments of the healthcare market in Austria over the last three years? To start with, even though…
In Conversation
“ Mr. Cooke, you joined Alkermes after the company acquired the Elan Drug Technologies (EDT) unit in 2011—a unit you headed for four years. Can you please… ”
“ Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? ”
Mylan embarked upon its first major international expansion program in 2007, after the acquisition of Merck KGaA’s generic medicines business. How has the organization subsequently evolved…
“ Mr. Keogh, you founded Millmount Healthcare in 1999. What was the vision behind the company? ”
One of NNE Pharmaplan’s latest exciting news is that last year you established offices to accommodate your existing customers in Belgium. What were the strategic motivations…
You have been with Grünenthal since 2004 and as the Austria Country Manager since June 2012. What were your initial goals when you took up the…
Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a top-ten player…
Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen…
Coming back to Dr. Paul’s spirit and philosophy, we are constantly trying to foster an environment of collaboration and communication which results in synergies and innovation.'
You have had an extensive career at the company, since 1989. What does the company have to offer that has made you stay so long and…
Can you please introduce us to Dalkia? Pat Gilroy: Dalkia is a multinational company that operates in over 40 countries throughout the world and turns over…
